Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 154 páginas
Examen

WGU D116 ADVANCED PHARMACOLOGY FINAL EXAM OBJECTIVE ASSEMENT & PRE-ASSESMENT 700 QUESTIONS AND ANSWERS LATEST UPDATE THIS YEAR - JUST RELEASED

Document preview thumbnail
Vista previa 4 fuera de 154 páginas

Ace the WGU D116 Advanced Pharmacology Final Exam with this comprehensive 2026 practice test bank featuring 700+ exam-style questions with verified answers and detailed rationales – all graded A+. Administered by Western Governors University (WGU), the D116 Advanced Pharmacology Objective Assessment (OA) evaluates specialized knowledge in safe prescribing and clinical decision-making for the Advanced Practice Registered Nurse (APRN). This resource covers all seven official D116 content domains: Pharmacokinetics & Pharmacodynamics (15%) including ADME, first-pass metabolism, and receptor pharmacology; Cardiovascular & Renal Pharmacology (20%) covering antihypertensives, diuretics, and anticoagulants; Respiratory & Allergy Pharmacology (10%); Endocrine & Metabolic Pharmacology (15%) including diabetes management and thyroid agents; Neurologic & Psychiatric Pharmacology (15%) covering antidepressants, antipsychotics, and anticonvulsants; Infectious Disease & Antimicrobials (15%); and Special Populations, Toxicology & Clinical Application (10%). Each question includes a verified correct answer and detailed clinical rationale. The WGU D116 course requires active RN licensure or equivalent healthcare background. Updated for the 2026/2027 testing cycle.

Vista previa del contenido

WGU D116 ADVANCED PHARMACOLOGY
FINAL EXAM OBJECTIVE ASSEMENT & PRE-
ASSESMENT 700 QUESTIONS AND ANSWERS
LATEST UPDATE THIS YEAR - JUST RELEASED

SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS

Question 1
Which of the following best describes pharmacokinetics?

A) The study of drug effects on the body
B) The study of drug absorption, distribution, metabolism, and excretion (ADME)
C) The study of drug toxicity
D) The study of drug interactions

Correct Answer: B) The study of drug absorption, distribution, metabolism, and
excretion (ADME)

Rationale: Pharmacokinetics is "what the body does to the drug" and encompasses the
four processes of Absorption, Distribution, Metabolism, and Excretion (ADME).
Pharmacodynamics, in contrast, is "what the drug does to the body"—the study of drug
effects and mechanisms of action.



Question 2
The "first-pass effect" refers to:

A) Rapid intravenous administration
B) Drug metabolism in the liver before reaching systemic circulation
C) Drug excretion by the kidneys
D) Drug binding to plasma proteins

Correct Answer: B) Drug metabolism in the liver before reaching systemic
circulation

,Rationale: The first-pass effect occurs when a drug is metabolized in the liver before
reaching systemic circulation, which reduces the bioavailability of orally administered
drugs. Drugs like nitroglycerin and morphine require higher oral doses or alternative
routes to bypass this effect.



Question 3
Bioavailability is defined as:

A) The speed of drug absorption
B) The fraction of an administered dose that reaches systemic circulation unchanged
C) The volume of distribution
D) The half-life of the drug

Correct Answer: B) The fraction of an administered dose that reaches systemic
circulation unchanged

Rationale: Bioavailability measures how much of an administered dose reaches the
bloodstream unchanged. Intravenous (IV) administration has 100% bioavailability because
it bypasses absorption and first-pass metabolism.



Question 4
Which route of administration has the highest bioavailability and fastest onset of action?

A) Oral
B) Subcutaneous
C) Intravenous (IV)
D) Intramuscular (IM)

Correct Answer: C) Intravenous (IV)

Rationale: IV administration bypasses absorption barriers and first-pass metabolism,
delivering 100% of the dose directly into systemic circulation. It also provides the most
rapid onset of action and is used in emergencies requiring immediate drug effect.

,Question 5
A drug with a half-life of 4 hours is administered every 4 hours. Approximately how
many half-lives are required to reach steady-state concentrations?

A) 1
B) 2
C) 4-5
D) 8

Correct Answer: C) 4-5

Rationale: Steady-state is typically achieved after 4–5 half-lives, regardless of dosing
interval, because the amount of drug eliminated equals the amount administered over
time.



Question 6
Which organ is primarily responsible for drug metabolism?

A) Kidneys
B) Liver
C) Lungs
D) Intestines

Correct Answer: B) Liver

Rationale: The liver is the primary site of drug metabolism, containing high concentrations
of drug-metabolizing enzymes, particularly the Cytochrome P450 (CYP) enzyme system.



Question 7
Which CYP enzyme is responsible for metabolizing the largest number of drugs
(approximately 50%)?

A) CYP2D6
B) CYP1A2
C) CYP3A4
D) CYP2C9

, Correct Answer: C) CYP3A4

Rationale: CYP3A4 metabolizes approximately 50% of all drugs, including statins, calcium
channel blockers, macrolide antibiotics, and many others. It is located in both the liver and
small intestine and is involved in numerous drug-drug interactions.



Question 8
Which route of administration completely avoids first-pass metabolism?

A) Oral
B) Sublingual
C) Rectal
D) Enteric-coated oral

Correct Answer: B) Sublingual

Rationale: Sublingual administration allows direct absorption into systemic circulation,
completely bypassing hepatic first-pass metabolism.



Question 9
A patient with liver cirrhosis is prescribed propranolol. The APRN understands that the
oral bioavailability of this drug will be significantly increased due to which
pharmacokinetic phenomenon?

A) Increased volume of distribution
B) Decreased first-pass metabolism
C) Enhanced renal tubular secretion
D) Increased plasma protein binding

Correct Answer: B) Decreased first-pass metabolism

Rationale: Propranolol undergoes extensive first-pass hepatic metabolism. In cirrhosis,
reduced hepatic blood flow and decreased enzyme activity reduce first-pass extraction,
thereby increasing oral bioavailability. This is a classic example of how hepatic
impairment alters pharmacokinetics.

Información del documento

Subido en
19 de septiembre de 2026
Número de páginas
154
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$19.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
AcademicACHIEVER
3.3
(91)
Vendido
533
Seguidores
22
Artículos
12858
Última venta
18 horas hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes